MOESM1 of Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis

Additional file 1: Figure S1. Egger’s funnel plot for publication bias test of the long-term prognostic outcomes of anti-PD-1/PD-L1 therapy, P=0.203.